NYSE:ZBH

Zimmer Biomet - ZBH Stock Forecast, Price & News

$119.01

+1.34 (+1.14%)

(As of 11/29/2022 03:59 PM ET)

Add

Compare

Today's Range: $117.38
▼
$119.32
50-Day Range: $104.55
▼
$119.21
52-Week Range: $100.39
▼
$135.05

Volume: 30,904 shs
Average Volume: 1.18 million shs
Market Capitalization: $24.97 billion

P/E Ratio: 90.16
Dividend Yield: 0.81%
Price Target: $124.05

Zimmer Biomet MarketRank™ Forecast

Analyst Rating: Hold
2.05 Rating Score
Upside/Downside: 4.5% Upside
$124.05 Price Target
Short Interest: Healthy
1.08% of Shares Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: -1.33
Upright™ Environmental Score
News Sentiment: 0.41
Based on 5 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 1.46%
From $6.84 to $6.94 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.38 out of 5 stars

Medical Sector

247th out of 1,038 stocks

Surgical Appliances & Supplies Industry

12th out of 24 stocks

2.0

Analyst's Opinion

Consensus Rating
Zimmer Biomet has received a consensus rating of Hold. The company's average rating score is 2.05, and is based on 4 buy ratings, 14 hold ratings, and 3 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $124.05, Zimmer Biomet has a forecasted upside of 4.5% from its current price of $118.66.
Amount of Analyst Coverage
Zimmer Biomet has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

5.0

Short Interest

Percentage of Shares Shorted
1.08% of the outstanding shares of Zimmer Biomet have been sold short.
Short Interest Ratio / Days to Cover
Zimmer Biomet has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Zimmer Biomet has recently decreased by 16.61%, indicating that investor sentiment is improving significantly.

1.7

Dividend Strength

Dividend Yield
Zimmer Biomet has a dividend yield of 0.81%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Zimmer Biomet has only been increasing its dividend for 1 years.
Dividend Coverage
The dividend payout ratio of Zimmer Biomet is 72.73%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Zimmer Biomet will have a dividend payout ratio of 13.83% next year. This indicates that Zimmer Biomet will be able to sustain or increase its dividend.

3.7

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Zimmer Biomet has received a 47.23% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Dental prostheses", "Surgery simulation software", "Dental implants", and "Prostheses" products. See details.
Environmental Sustainability
The Environmental Impact score for Zimmer Biomet is -1.33.

1.9

News and Social Media Coverage

News Sentiment
Zimmer Biomet has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for Zimmer Biomet this week, compared to 5 articles on an average week.
Search Interest
Only 4 people have searched for ZBH on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.
MarketBeat Follows
9 people have added Zimmer Biomet to their MarketBeat watchlist in the last 30 days. This is an increase of 80% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Zimmer Biomet insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.73% of the stock of Zimmer Biomet is held by insiders.
Percentage Held by Institutions
89.39% of the stock of Zimmer Biomet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Zimmer Biomet are expected to grow by 1.46% in the coming year, from $6.84 to $6.94 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Zimmer Biomet is 89.89, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 124.05.
Price to Earnings Ratio vs. Sector
The P/E ratio of Zimmer Biomet is 89.89, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 108.95.
Price to Earnings Growth Ratio
Zimmer Biomet has a PEG Ratio of 2.27. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Zimmer Biomet has a P/B Ratio of 1.96. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Zimmer Biomet (NYSE:ZBH) Stock

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Receive ZBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zimmer Biomet and its competitors with MarketBeat's FREE daily newsletter.

ZBH Stock News Headlines

November 27, 2022 | americanbankingnews.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Given Consensus Recommendation of "Hold" by Brokerages

November 26, 2022 | americanbankingnews.com

Wells Fargo & Company Upgrades Zimmer Biomet (NYSE:ZBH) to "Equal Weight"

November 21, 2022 | finance.yahoo.com

Zimmer Biomet Expands Persona® Knee System Portfolio with FDA Clearance of Persona® OsseoTi® Keel Tibia for Cementless Knee Replacement

November 21, 2022 | finance.yahoo.com

Zimmer Biomet to Present at the 34th Annual Piper Sandler Healthcare Conference

November 20, 2022 | americanbankingnews.com

FY2022 EPS Estimates for Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Increased by Zacks Research

November 10, 2022 | finance.yahoo.com

ZimVie Inc. (ZIMV) Q3 2022 Earnings Call Transcript

November 8, 2022 | finance.yahoo.com

Zimmer Biomet Holdings Third Quarter 2022 Earnings: Beats Expectations

November 5, 2022 | markets.businessinsider.com

Zimmer Biomet Reports Positive Data From Mymobility Clinical Study

November 4, 2022 | markets.businessinsider.com

Robert W. Baird Reaffirms Their Buy Rating on Zimmer Biomet Holdings (ZBH)

November 4, 2022 | finance.yahoo.com

Is Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Recent Price Movement Underpinned By Its Weak Fundamentals?

November 3, 2022 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD) and Zimmer Biomet Holdings (ZBH)

November 2, 2022 | seekingalpha.com

Zimmer Biomet Holdings, Inc. (ZBH) Q3 2022 Earnings Call Transcript

November 2, 2022 | finance.yahoo.com

Zimmer Biomet (ZBH) Surpasses Q3 Earnings and Revenue Estimates

November 2, 2022 | finance.yahoo.com

Zimmer Biomet (ZBH) Q3 Earnings Beat, Gross Margin Falls

November 2, 2022 | markets.businessinsider.com

Zimmer Biomet Holdings Inc. Q3 Income Advances

October 20, 2022 | msn.com

Patients are getting surgeries again, says J&J

October 20, 2022 | nasdaq.com

Zimmer Biomet Holdings, Inc. Common Stock (ZBH)

October 17, 2022 | finance.yahoo.com

Is There An Opportunity With Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) 35% Undervaluation?

October 15, 2022 | seekingalpha.com

ZBH Zimmer Biomet Holdings, Inc.

October 7, 2022 | nasdaq.com

Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) P/E Still Appears To Be Reasonable

October 5, 2022 | finance.yahoo.com

Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2022 Financial Results

September 21, 2022 | finance.yahoo.com

Zimmer Biomet (ZBH) to Offer New Shoulder Replacement System

September 20, 2022 | markets.businessinsider.com

Zimmer Biomet Receives FDA 510(k) Clearance For Identity Shoulder System

September 20, 2022 | finance.yahoo.com

Zimmer Biomet Receives FDA Clearance for Identity™ Shoulder System for Shoulder Replacement

September 13, 2022 | finance.yahoo.com

Zimmer (ZBH) Surges 4.2%: Is This an Indication of Further Gains?

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive ZBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zimmer Biomet and its competitors with MarketBeat's FREE daily newsletter.

ZBH Company Calendar

Ex-Dividend for 10/31 Dividend: 9/29/2022
Dividend Payable: 10/31/2022
Last Earnings: 11/02/2022
Today: 11/29/2022
Fiscal Year End: 12/31/2022
Next Earnings (Estimated): 2/06/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Surgical appliances & supplies
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:ZBH
Previous Symbol: NYSE:ZMH
CUSIP: N/A
CIK: 1136869
Web: www.zimmerbiomet.com
Phone: (574) 267-6131
Fax: 574-372-4988
Employees: 19,500
Year Founded: 1927

Price Target and Rating

Average Stock Price Forecast: $124.05
High Stock Price Forecast: $155.00
Low Stock Price Forecast: $95.00
Forecasted Upside/Downside: +4.2%
Consensus Rating: Hold
Rating Score (0-4): 2.05
Research Coverage: 21 Analysts

Profitability

EPS (Most Recent Fiscal Year): $1.32
Trailing P/E Ratio: 90.16
Forward P/E Ratio: 17.40
P/E Growth: 2.27
Net Income: $401.60 million
Net Margins: 3.89%
Pretax Margin: 4.39%
Return on Equity: 11.92%
Return on Assets: 6.66%

Debt

Debt-to-Equity Ratio: 0.41
Current Ratio: 1.98
Quick Ratio: 1.05

Sales & Book Value

Annual Sales: $7.84 billion
Price / Sales: 3.19
Cash Flow: $12.59 per share
Price / Cash Flow: 9.45
Book Value: $60.63 per share
Price / Book: 1.96

Miscellaneous

Outstanding Shares: 209,850,000
Free Float: 208,320,000
Market Cap: $24.97 billion
Optionable: Optionable
Beta: 1.08

Social Links

Key Executives

Mr. Bryan C. Hanson (Age 55)
Chairman, Pres & CEO
Comp: $3.33M

Mr. Suketu P. Upadhyay (Age 53)
Exec. VP & CFO
Comp: $1.62M

Mr. Ivan Tornos (Age 46)
Chief Operating Officer
Comp: $1.68M

Mr. Sang Yi (Age 60)
Group Pres of Asia Pacific
Comp: $1.22M

Mr. Wilfred van Zuilen
Pres of Europe, Middle East & Africa

Mr. Paul A. Stellato (Age 47)
VP, Controller & Chief Accounting Officer

Dr. Nitin Goyal M.D.
Chief Science, Technology & Innovation Officer

Mr. Zeeshan Tariq
Sr. VP & Chief Information Officer

Ms. Keri P. Mattox
Chief Communications & Admin. Officer and Sr. VP of Investor Relations

Mr. Chad F. Phipps (Age 50)
Sr. VP, Gen. Counsel & Sec.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ZBH Stock - Frequently Asked Questions

Should I buy or sell Zimmer Biomet stock right now?: 21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zimmer Biomet in the last year. There are currently 3 sell ratings, 14 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" ZBH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ZBH, but not buy additional shares or sell existing shares.
View ZBH analyst ratings or view top-rated stocks.
What is Zimmer Biomet's stock price forecast for 2023?: 21 brokerages have issued twelve-month price objectives for Zimmer Biomet's shares. Their ZBH share price forecasts range from $95.00 to $155.00. On average, they predict the company's stock price to reach $124.05 in the next year. This suggests a possible upside of 5.4% from the stock's current price.
View analysts price targets for ZBH or view top-rated stocks among Wall Street analysts.
How have ZBH shares performed in 2022?: Zimmer Biomet's stock was trading at $127.04 at the beginning of the year. Since then, ZBH shares have decreased by 7.4% and is now trading at $117.67.
View the best growth stocks for 2022 here.
When is Zimmer Biomet's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, February 6th 2023.
View our ZBH earnings forecast.
How were Zimmer Biomet's earnings last quarter?: Zimmer Biomet Holdings, Inc. (NYSE:ZBH) posted its quarterly earnings results on Wednesday, November, 2nd. The medical equipment provider reported $1.58 earnings per share for the quarter, beating analysts' consensus estimates of $1.56 by $0.02. The medical equipment provider earned $1.67 billion during the quarter, compared to analyst estimates of $1.64 billion. Zimmer Biomet had a net margin of 3.89% and a trailing twelve-month return on equity of 11.92%. The firm's revenue for the quarter was down 13.2% on a year-over-year basis. During the same period last year, the business earned $1.81 EPS.
Read the conference call transcript.
How often does Zimmer Biomet pay dividends? What is the dividend yield for Zimmer Biomet?: Zimmer Biomet declared a quarterly dividend on Friday, August 26th. Investors of record on Friday, September 30th will be paid a dividend of $0.24 per share on Monday, October 31st. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.82%. The ex-dividend date is Thursday, September 29th.
Read our dividend analysis for ZBH.
Is Zimmer Biomet a good dividend stock?: Zimmer Biomet (NYSE:ZBH) pays an annual dividend of $0.96 per share and currently has a dividend yield of 0.81%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 72.73%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ZBH will have a dividend payout ratio of 13.83% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ZBH.
What guidance has Zimmer Biomet issued on next quarter's earnings?: Zimmer Biomet issued an update on its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share guidance of $6.80-$6.90 for the period, compared to the consensus EPS estimate of $6.79. The company issued revenue guidance of $7.84 billion-$7.91 billion, compared to the consensus revenue estimate of $6.86 billion.

What is Bryan Hanson's approval rating as Zimmer Biomet's CEO?: 240 employees have rated Zimmer Biomet Chief Executive Officer Bryan Hanson on Glassdoor.com. Bryan Hanson has an approval rating of 87% among the company's employees. 66.0% of employees surveyed would recommend working at Zimmer Biomet to a friend.
What other stocks do shareholders of Zimmer Biomet own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Zimmer Biomet investors own include AT&T (T), Walt Disney (DIS), Johnson & Johnson (JNJ), Bristol-Myers Squibb (BMY), Cisco Systems (CSCO), Merck & Co., Inc. (MRK), Intel (INTC), AbbVie (ABBV), NVIDIA (NVDA) and JPMorgan Chase & Co. (JPM).
What is Zimmer Biomet's stock symbol?: Zimmer Biomet trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."
Who are Zimmer Biomet's major shareholders?: Zimmer Biomet's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (11.35%), BlackRock Inc. (10.24%), Price T Rowe Associates Inc. MD (5.03%), State Street Corp (4.11%), Primecap Management Co. CA (2.34%) and Boston Partners (1.26%). Insiders that own company stock include Arthur J Higgins, Bryan C Hanson, Chad F Phipps, Sang Yi and Zuilen Wilfred Van.
View institutional ownership trends.
How do I buy shares of Zimmer Biomet?: Shares of ZBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Zimmer Biomet's stock price today?: One share of ZBH stock can currently be purchased for approximately $117.67.
How much money does Zimmer Biomet make?: Zimmer Biomet (NYSE:ZBH) has a market capitalization of $24.69 billion and generates $7.84 billion in revenue each year. The medical equipment provider earns $401.60 million in net income (profit) each year or $1.32 on an earnings per share basis.
How many employees does Zimmer Biomet have?: The company employs 19,500 workers across the globe.
Does Zimmer Biomet have any subsidiaries?: The following companies are subsidiares of Zimmer Biomet: Abbott Spine, Beijing Montagne Medical Device Co. Ltd., Beijing Montagne Medical Device Co. Ltd., BioMet, Biomet 3i Australia Pty. Ltd., Biomet 3i Belgium N.V., Biomet 3i Benelux Holdings N.V., Biomet 3i Dental Iberica SL, Biomet 3i LLC, Biomet 3i Mexico S.A. de C.V., Biomet 3i Netherlands B.V., Biomet 3i Nordic AB, Biomet 3i Portugal Lda, Biomet 3i Switzerland GmbH, Biomet 3i Turkey, Biomet 3i UK Ltd., Biomet 3i do Brasil Comercio de Aparelhos Medicos Ltda., Biomet Acquisitions (Unlimited), Biomet Argentina SA, Biomet Australia Pty. Ltd., Biomet Biologics LLC, Biomet Brazil Medical Device Ltda., Biomet C.V., Biomet CV Holdings LLC, Biomet Cementing Technologies AB, Biomet Chile SA, Biomet China Co. Ltd., Biomet Deutschland GmbH, Biomet Deutschland Holding GmbH, Biomet Fair Lawn LLC, Biomet Finance US LLC, Biomet France Sarl, Biomet Global Supply Chain Center B.V., Biomet Healthcare Management GmbH, Biomet Holdings B.V., Biomet Hong Kong CBT Ltd., Biomet Hong Kong Holding Ltd., Biomet Hong Kong No. 1 Ltd., Biomet Inc., Biomet Insurance Ltd., Biomet International Inc., Biomet International Orthopedics LLC, Biomet Leasing Inc., Biomet Manufacturing LLC, Biomet Mexico S.A. de C.V., Biomet Microfixation B.V., Biomet Orthopedics LLC, Biomet Orthopedics Puerto Rico Inc., Biomet Spain Orthopaedics S.L., Biomet Sports Medicine LLC, Biomet Trauma LLC, Biomet U.S. Reconstruction LLC, Biomet UK Healthcare Ltd., Biomet UK Ltd., CD Diagnostics, CD Diagnostics Inc., CD Laboratories Inc., Cayenne Medical, Cayenne Medical Inc., CelgenTek Innovations Corporation, Centerpulse Ltd, Changzhou Biomet Medical Devices Co. Ltd., Citra Labs LLC, Clinical Graphics, Compression Therapy Concepts Inc., Compression Therapy Products, D.S. Comp Ltd., Dornoch Medical Systems, Dornoch Medical Systems Inc., EBI Holdings LLC, EBI LLC, EBI Medical Systems LLC, EBI Patient Care Inc., ETEX Corporation, ETEX Holdings Inc., Electro-Biology LLC, Endius, Espanormed S.L., Etex, ExtraOrtho, Hakuho Company Ltd., IC Guided Surgery SRL, Implant Concierge LLC, Implant Innovations Holdings LLC, Implex, InnoVision Inc., Interpore Cross International LLC, JERDS Luxembourg Holding Sarl, Kirschner Medical Corporation, Knee Creations, LDR Brasil Comercio Importacao e Exportacao Ltda., LDR Holding, LDR Medical Hong Kong (branch), LDR Médical S.A.S., LVB Acquisition Inc., Lanx Puerto Rico LLC , Lanx Srl, Medical Compression Systems Inc., Medtech SA, Medtech SAS, Medtech Surgical GmbH, Medtech Surgical Inc., NORMED Medizin-Technik GmbH, ORTHOsoft ULC, Ortho Transmission, Orthopaedic Advantage LLC, Ospol Participacoes Ltda., Representaciones Zimmer Inc. S. de R.L. de C.V., Respondwell, SM Re Ltd., Scandimed Holding AB, Shanghai Biomet Business Consulting Co. Ltd., Synvasive Technology, Synvasive Technology Inc., ZB COOP C.V., ZB COOP LLC, ZB Cayman (Asia) Holding Ltd., ZB Cayman Island CBT 2 Ltd., ZB Dental India Private Limited, ZB EMEA 1 LP, ZB EMEA Finance UK 1 Ltd., ZB EMEA Finance UK 2 Ltd., ZB EMEA Finance UK 3 Ltd., ZB EMEA US UK LLC, ZB Hong Kong CBT 2 Ltd., ZB Hong Kong Holding Ltd., ZB Hong Kong Ltd., ZB Manufacturing LLC, ZB UK Group Holdings Limited, ZH2LX Barbados Branch (branch), Zfx, Zfx GmbH, Zfx Innovation GmbH, Zhejiang Biomet Medical Products Co. Ltd., Zimmer (Shanghai) Medical International Trading Co. Ltd., Zimmer Asia (HK) Ltd., Zimmer Australia Holding Pty. Ltd., Zimmer Biomet (Thailand) Co. Ltd., Zimmer Biomet Asel Alarabiya Limited Company, Zimmer Biomet Asia Holding B.V., Zimmer Biomet Asia Holdings Pte. Ltd., Zimmer Biomet Austria GmbH, Zimmer Biomet BVBA, Zimmer Biomet CBT, Zimmer Biomet CBT 2, Zimmer Biomet CMF and Thoracic LLC, Zimmer Biomet Canada Inc., Zimmer Biomet Centroamerica SA, Zimmer Biomet Comp Ltd., Zimmer Biomet Denmark ApS, Zimmer Biomet Dental Canada Inc., Zimmer Biomet Dental K.K., Zimmer Biomet Deutschland GmbH, Zimmer Biomet Distribution LLC, Zimmer Biomet Finance Srl, Zimmer Biomet Finance US Holding Inc., Zimmer Biomet Finland Oy, Zimmer Biomet France Holdings SAS, Zimmer Biomet France SAS, Zimmer Biomet GK, Zimmer Biomet Global Holdings Switzerland GmbH, Zimmer Biomet Hellas SA, Zimmer Biomet Ireland Limited, Zimmer Biomet Italia Srl, Zimmer Biomet Korea Ltd., Zimmer Biomet Nederland B.V., Zimmer Biomet New Zealand Company, Zimmer Biomet Norway AS, Zimmer Biomet OUS Holdings AG, Zimmer Biomet Polska Sp. z.o.o, Zimmer Biomet Portugal Unipessoal Lda, Zimmer Biomet Pty. Ltd., Zimmer Biomet Romania S.R.L., Zimmer Biomet South Africa (Pty) Ltd., Zimmer Biomet Spain S.L., Zimmer Biomet Spine Inc., Zimmer Biomet Sweden AB, Zimmer Biomet Taiwan Co. Ltd., Zimmer Biomet UK Ltd., Zimmer Biomet US 2 Holding Inc., Zimmer CBT I Holding Inc., Zimmer CBT II Holding Inc., Zimmer CEP USA Holding Co., Zimmer CEP USA Inc., Zimmer CIS Ltd., Zimmer CV Inc., Zimmer Caribe LLC, Zimmer Cayman Islands Holding Co. Ltd., Zimmer Co-op Holdings LLC, Zimmer Colombia SAS, Zimmer Czech sro, Zimmer Dental (Shanghai) Medical Device Co. Ltd., Zimmer Dental Chile Spa, Zimmer Dental GmbH, Zimmer Dental Inc., Zimmer Dental Italy Srl, Zimmer Dental Ltd., Zimmer Dental SAS, Zimmer Finance Ireland, Zimmer France Manufacturing Sarl, Zimmer Germany Holdings GmbH, Zimmer GmbH, Zimmer GmbH Euro IP Branch (branch), Zimmer GmbH Winterthur Branch (branch), Zimmer Gulf FZ LLC, Zimmer Inc., Zimmer India Private Ltd., Zimmer International Logistics GmbH, Zimmer Investments LLC, Zimmer Knee Creations Inc., Zimmer Luxembourg II Sarl, Zimmer Luxembourg Sarl, Zimmer Manufacturing B.V., Zimmer Manufacturing B.V. (branch), Zimmer Medical Malaysia SDN BHD, Zimmer Netherlands Cooperatief U.A., Zimmer Orthobiologics Inc., Zimmer Orthopedics Manufacturing Limited, Zimmer Production Inc., Zimmer Pte. Ltd., Zimmer Slovakia sro, Zimmer Southeast Florida LLC, Zimmer Spine Next Inc., Zimmer Spine SAS, Zimmer Surgical, Zimmer Surgical Inc., Zimmer Surgical SA, Zimmer Switzerland Holdings LLC, Zimmer Switzerland Manufacturing GmbH, Zimmer Tibbi Cihazlar Sanayi ve Ticaret AS, Zimmer Trabecular Metal Technology Inc., Zimmer Trustee Ltd., Zimmer UK Limited, Zimmer US Inc., and Zimmer do Brasil Comercio Ltda..
Read More
How can I contact Zimmer Biomet?: Zimmer Biomet's mailing address is 345 EAST MAIN STREET, WARSAW IN, 46580. The official website for the company is www.zimmerbiomet.com. The medical equipment provider can be reached via phone at (574) 267-6131, via email at keri.mattox@zimmerbiomet.com, or via fax at 574-372-4988.

This page (NYSE:ZBH) was last updated on 11/29/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial